← Eichor
Study identifier: NCT06050980 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation

Condition: NSCLC  ·  Sponsor: Haisco Pharmaceutical Group Co., Ltd.

PhasePhase 1
Planned participants220
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a phase I, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK and PD of HSK40118 when given orally in patients with active EGFR mutation locally advanced or metastatic non-small cell lung cancer (NSCLC). The study will contain two phase: Phase Ia is dose escalation phase and Phase Ib is dose expansion phase.

This description comes directly from the study's public registry record.

Talk to the study team

Fangqiong Li  ·  +8602867258840  ·  lifangq@haisco.com

Always discuss trial participation with your own doctor first.

Locations (12)

Cancer Hospital Chinese Academy of Medical SciencesBeijing, Beijing Municipality, ChinaRecruiting
Chongqing Cancer HospitalChongqing, Chongqing Municipality, ChinaRecruiting
Fujian Cancer HospitalFuzhou, Fujian, ChinaRecruiting
Guangxi Medical University Cancer HospitalNanning, Guangxi, ChinaRecruiting
Harbin Medical University Cancer HospitalHarbin, Heilongjiang, ChinaRecruiting
First Affiliated Hospital of Henan University of Science and TechnologyLuoyang, Henan, ChinaRecruiting
Henan Cancer HospitalZhengzhou, Henan, ChinaRecruiting
Hunan Cancer HospitalChangsha, Hunan, ChinaRecruiting
The First Hospital of China Medical UniversityShenyang, Liaoning, ChinaRecruiting
Shandong Cancer HospitalJinan, Shandong, ChinaRecruiting
Shanghai Pulmonary HospitalShanghai, Shanghai Municipality, ChinaRecruiting
Taizhou hospital of Zhejiang ProvinceTaizhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06050980